$ABVX Obefazimod induction NON-RESPONDERS achieved a higher endoscopic remission rate than RINVOQ INDUCTION RESPONDERS, which previously held the record for highest ER scores...
NONRESPONDERS ENDED UP WITH HIGHER REMISSION RATES THAN ***RESPONDERS*** OF THE PREVIOUSLY MOST EFFICACIOUS DRUG ON THE MARKET
I cannot stress out INSANE $ABVX efficacy is. It is off. the. charts.
Oh, and that PREVIOUSLY best efficacy drug has 5 black box warnings. With the malignancy rates coming in "in-range" for $ABVX this afternoon, OBEFAZIMOD WILL HAVE ***ZERO*** BLACK BOX WARNINGS.